研究成果・実績

Clozapine treatment is associated with higher prescription rate of antipsychotic monotherapy and lower prescription rate of other concomitant psychotropics: A real-world nationwide study.

Ochi S, Tagata H, Hasegawa N, Yasui-Furukori N, Iga JI, Kashiwagi H, Kodaka F, Komatsu H, Tsuboi T, Tokutani A, Numata S, Ichihashi K, Onitsuka T, Muraoka H, Iida H, Ohi K, Atake K, Kishimoto T, Hori H, Takaesu Y, Takeshima M, Usami M, Makinodan M, Hashimoto N, Fujimoto M, Furihata R, Nagasawa T, Yamada H, Matsumoto J, Miura K, Kido M, Hishimoto A, Ueno SI, Watanabe K, Inada K, Hashimoto R. Int J Neuropsychopharmacol. 2022 Jun 20:pyac036.

Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry.

Ogasawara K, Numata S, Hasegawa N, Nakataki M, Makinodan M, Ohi K, Takeshima M, Tsuboi T, Hashimoto N, Onitsuka T, Muraoka H, Hori H, Ichihashi K, Inagaki T, Yasui-Furukori N, Hishimoto A, Sugiyama N, Fukumoto K, Nagasawa T, Matsumoto J, Takaesu Y, Furihata R, Nemoto K, Nakamura T, Usami M, Miura K, Fujimoto M, Tagata H, Yamada H, Komatsu H, Ochi S, Atake K, Katsumoto E, Kido M, Kishimoto T, Suwa T, Yamamura S, Iga JI, Iida H, Inada K, Watanabe K, Hashimoto R. Neuropsychopharmacol Rep. 2022 Jun;42(2):221-225.

Advantages and disadvantages of the long-term use of telepsychiatry.

Kinoshita S, Kishimoto T. Ir J Psychol Med. 2023 Sep;40(3):538-539.

Efficacy and acceptability of remote cognitive behavioral therapy for patients with major depressive disorder in Japanese clinical settings: A case series.

Nogami W, Nakagawa A, Kato N, Sasaki Y, Kishimoto T, Horikoshi M, Mimura M. Cogn Behav Pract. 2022 May 5.

Efficacy and safety/tolerability of antipsychotics in the treatment of adult patients with major depressive disorder: a systematic review and meta-analysis.

Kishimoto T, Hagi K, Kurokawa S, Kane JM, Correll CU. Psychol Med. 2022 May 5:1-19.

Characteristics of single-channel electroencephalogram in depression during conversation with noise reduction technology.

Mitsukura Y, Tazawa Y, Nakamura R, Sumali B, Nakagawa T, Hori S, Mimura M, Kishimoto T. PLoS One. 2022 Apr 13;17(4):e0266518.

A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project.

Yamada H, Motoyama M, Hasegawa N, Miura K, Matsumoto J, Ohi K, Yasui-Furukori N, Numata S, Takeshima M, Sugiyama N, Nagasawa T, Kubota C, Atake K, Tsuboi T, Ichihashi K, Hashimoto N, Inagaki T, Takaesu Y, Iga JI, Hori H, Onitsuka T, Komatsu H, Hishimoto A, Fukumoto K, Fujimoto M, Nakamura T, Nemoto K, Furihata R, Yamamura S, Yamagata H, Ogasawara K, Katsumoto E, Murata A, Iida H, Ochi S, Makinodan M, Kido M, Kishimoto T, Yasuda Y, Usami M, Suwa T, Inada K, Watanabe K, Hashimoto R.BJPsych Open. 2022 Apr 21;8(3):e83.

Association of work environment with stress and depression among Japanese workers.

Shiga K, Izumi K, Minato K, Yoshimura M, Kitazawa M, Hanashiro S, Cortright K, Kurokawa S, Momota Y, Sado M, Maeno T, Takebayashi T, Mimura M, Kishimoto T. Work. 2022;72(4):1321-1335.

The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project.

Ichihashi K, Kyou Y, Hasegawa N, Yasui-Furukori N, Shimnizu Y, Hori H, Hashimoto N, Ide K, Imamura Y, Yamada H, Ochi S, Iga J, Takaesu Y, Ohi K, Tsuboi T, Iida H, Yamagata H, Hishimoto A, Horai T, Usami M, Makinodan M, Nagasawa T, Komatsu H, Kido M, Muraoka H, Atake K, Takeshima M, Kubota C, Inagaki T, Tamai S, Kishimoto T, Furihata R, Matsumoto J, Miura K, Inada K, Watanabe K, Kasai K, Hashimoto R. Asian J Psychiatr. 2022; 69:103007.

Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times – Children and Adolescents (COH-FIT-C&A).

Solmi M, Estradé A, Thompson Tet al. J Affect Disord. 2022;299:367-376.